Health Guide for Sickle Cell Anemia and Pregnancy for African Patients

Sickle Cell Anemia and Pregnancy for African Patients a safe journey for Nigeria & Kenya patients. We provide top doctors, medical visas & 24/7 family support.

Health Guide for Sickle Cell Anemia and Pregnancy for African Patients

  • Category

    Oncology

  • Published By

    GetWellGo Team

  • Updated on

    30-Jun-2025

Sickle Cell Anemia and Pregnancy

Sickle cell anemia (SCA) is a genetic blood disorder in which the red blood cells, which are usually round and elastic, become inflexible and crescent- or sickle-shaped. These deformed cells can obstruct blood flow, causing pain, damage to organs, and increased susceptibility to infections. Sickle cell anemia and pregnancy is high-risk because the mother and the fetus are more likely to develop complications. Nevertheless, with close medical supervision and attention, most women with SCA can experience successful pregnancies.

Relationship between Sickle Cell Anemia and Pregnancy

Sickle cell anemia and Pregnancy are closely related since pregnancy increases the physical demand on the body, which can aggravate the complications of SCA. Conversely, Sickle cell anemia influences the success of a pregnancy with the way it affects blood circulation, oxygen supply, and organ function.

This compatibility indicates:

Elevated Physical Requirement during Pregnancy

  • Pregnancy elevates blood volume, heart rate, and oxygen requirement.
  • Red blood cells are already defective in carrying oxygen in sickle cell anemia.
  • This worsens anemia and causes more frequent sickle cell crises (painful crises due obstructed blood vessels).

Vascular and Placental Complications

  • Sickle cells are adhesive and tend to obstruct blood vessels.

During pregnancy, this can impair placental blood flow, causing:

  • Poor oxygen and nutrient supply to the fetus
  • Risk of miscarriage, stillbirth, or intrauterine growth restriction (IUGR)

Decreased Immune Function and Infection

  • Sickle Cell Anemia and Pregnancy both compromise the immune system.
  • SCA women, who are pregnant, are at higher risk for infections (e.g., UTIs, pneumonia) that can initiate crises or cause preterm labor.

Complications Such as Preeclampsia and Blood Clots

  • SCA raises the risk of hypertension and preeclampsia.
  • The disease also raises the risks of clotting, and pregnancy already thins the blood, making it more susceptible to clots — doubling the threat.

Genetic Link

  • SCA is hereditary. An expectant mother with SCA can transmit the gene to the child.

If both parents have the sickle cell trait, there's a:

  • 25% chance the child will have sickle cell anemia
  • 50% chance the child will have the trait
  • 25% chance the child won't be affected

Sickle cell disease and pregnancy management

Sickle Cell Disease (SCD) and Pregnancy Management is best managed using a multidisciplinary team because of the added risks to both the fetus and mother. Below is an organized outline:

Overview of SCD in Pregnancy

  • Sickle Cell Disease is a hemoglobin genetic disorder that results in the sickling, vaso-occlusion, hemolytic anemia, and organ damage of red blood cells.
  • Pregnancy augments complications because of physiologic stress, hypercoagulability, and immune suppression.

Pregnancy risks with sickle cell anemia

Pregnancy Complications in Sickle Cell Anemia are much greater than in the general population because of the chronic disease complications and higher physiological demands of pregnancy. This is a structured summary:

Maternal Pregnancy Complications in Sickle Cell Disease:

Vaso-occlusive crises (VOCs)

  • Hypoxia-, dehydration-, infection-, or stress-induced painful episodes; more common in pregnancy.

Acute Chest Syndrome (ACS)

  • Life-threatening condition with chest pain, fever, and hypoxia; usually precipitated by infection or embolism.

Severe Anemia

  • Secondary to chronic hemolysis; can necessitate recurrent transfusions.

Infections

  • Functional asplenia leads to increased risk of UTIs, pneumonia, and sepsis.

Preeclampsia/Eclampsia

  • Increased risk of hypertensive disorders of pregnancy.

Thromboembolism

  • Increased risk secondary to hypercoagulability of pregnancy and SCD.

Pulmonary Hypertension

  • Can worsen during pregnancy and contribute to increased maternal mortality.

Stroke

  • Increased risk secondary to vaso-occlusion and anemia.

Maternal Mortality

  • 2–10 times that of the general population in some areas.

Fetal Risks in Pregnancy with Sickle Cell Anemia:

Intrauterine Growth Restriction (IUGR)

  • Placental insufficiency caused by sickling in placental vessels.

Preterm Labor and Birth

  • Frequently caused by maternal disease or iatrogenic induction.

Low Birth Weight

  • Frequent in SCD pregnancies.

Miscarriage

  • Increased risk, especially in poorly controlled disease.

Stillbirth

  • Increased because of fetal hypoxia and placental infarctions.

Neonatal Death

  • Risk increased particularly in low-resource settings.

Managing sickle cell anemia during pregnancy

Sickle cell anemia (SCA) management during pregnancy is a multidisciplinary, proactive, and individualized process aimed at optimizing maternal and fetal outcomes. The aim is prevention of complications, observation of maternal and fetal health, and safe delivery.

Preconception and Early Pregnancy Care

Preconception Counselling

  • Genetic testing and partner screening to determine fetal risk.

Baseline Evaluation

  • Complete blood count, hemoglobin electrophoresis, liver/renal function, cardiac and pulmonary evaluation.

Folic Acid

  • 4–5 mg daily to enhance production of red blood cells.

Vaccination Update

  • Pneumococcal, meningococcal, H. influenzae, hepatitis B, influenza.

Discontinue Teratogens

  • Discontinue hydroxyurea and other contraindicated medications prior to conception.

Antenatal Management

General Monitoring

  • Multidisciplinary Team: Obstetrician, hematologist, anesthetist, pediatrician.
  • Frequent Antenatal Visits: Every 2–4 weeks; more frequently in third trimester.
  • Serial Ultrasounds: Document fetal growth every 4 weeks from 24 weeks.

Maternal Monitoring

  • CBC, reticulocyte count, LFTs, RFTs every 4–6 weeks.
  • Screen for infections regularly (especially UTIs).
  • Avoid triggers: cold, dehydration, stress, overexertion.

Medications & Supplements

Folic acid

  • 4–5 mg daily during pregnancy.

Iron

  • Only if iron deficiency is diagnosed (not routine because of risk of iron overload).

Low-dose aspirin (75–150 mg)

  • Begin at 12 weeks to prevent preeclampsia.

Relief from pain

  • Paracetamol first choice; opioids if necessary. In late pregnancy, avoid NSAIDs.

Transfusion Strategy

Indicated for:

  • Symptomatic anemia (Hb <7 g/dL)
  • Frequent vaso-occlusive crises
  • Acute chest syndrome
  • Prevention of stroke
  • Prophylactic transfusions can be considered in serious cases or past adverse pregnancy outcome.

Management of Acute Complications

Vaso-occlusive crisis (VOC)

  • Hydration, oxygen, analgesics, rest; treat precipitants (e.g. infection).

Acute chest syndrome

  • Emergency hospitalization, oxygen, antibiotics, transfusion.

Severe anemia

  • Packed red cell transfusion.

Infections

  • Prompt antibiotics, particularly for UTI or resp infection.

Preeclampsia

  • Treat per obstetric protocol; delivery in severe cases or at or near term.

Intrapartum Care

Delivery Planning

  • At 37–39 weeks if stable. Earlier with complications.

Preferred Mode

  • Vaginal delivery unless obstetric need for cesarean.

Monitoring

  • Continuous fetal heart rate monitoring.

Pain Relief

  • Epidural is safe and preferred.

Hydration and Oxygen

  • Continue IV fluids and oxygenation through labor.

Postpartum Care

Watch for VOCs or ACS

  • Particularly in the first 72 hours postpartum.

Thromboprophylaxis

  • LMWH for 7 days after vaginal, 6 weeks after cesarean or high-risk.

Encourage Breastfeeding

  • Safe even on opioids or most medications.

Early Ambulation

  • To decrease risk of thrombosis.

Contraception Counselling

  • Progestin-only pills, implants, or IUDs. Avoid estrogen pills if risk of thrombosis.

Blood Cross-match

  • Have blood available in case of transfusion risk.

Sickle cell anemia and fetal health

Pregnancy in a woman with sickle cell anemia (SCA) is risky to the health of the fetus because of maternal complications such as anemia, vaso-occlusion, and placental insufficiency. These impair oxygen and nutrient delivery to the fetus, which influences growth and survival.

How Sickle Cell Anemia Affects the Fetus?

Placental vaso-occlusion

  • Decreased blood flow leads to intrauterine growth restriction (IUGR).

Chronic maternal anemia

  • Triggers fetal hypoxia, impaired growth, and enhanced distress.

Increased maternal infections

  • May cause preterm labor or fetal loss.

Sickling in placental vessels

  • Results in placental infarction, diminishing nutrient exchange.

Acute maternal complications (e.g. VOCs, ACS)

  • Can lead to precipitating fetal hypoxia, stillbirth, or preterm delivery.

Sickle cell anemia and pregnancy treatment options for African Patients

Management of sickle cell anemia and pregnancy is aimed at preventing and treating complications, enhancing maternal health, and promoting optimal fetal outcomes. Management is supportive, preventive, and tailored, depending on maternal status and pregnancy duration.

  • Supportive Therapy
  • Blood Transfusions
  • Drug Management
  • Prevention and Management of Infections
  • Fetal Monitoring and Surveillance
  • Intrapartum and Delivery Management
  • Postpartum Care

Sickle cell anemia and labor and delivery

Women with sickle cell anemia (SCA) are at risk of increased threats to both themselves and their infants during labor and delivery from the effects of anemia, vaso-occlusion, and organ dysfunction. Careful planning and support are necessary to provide safe outcomes for both mother and infant.

Most Important Objectives During Labor and Delivery

  • Avoid sickling crises
  • Provide oxygenation and hydration
  • Provide pain control
  • Monitor fetal distress
  • Prepare for emergencies

Sickle cell anemia and breastfeeding

Breastfeeding is not only safe but also highly recommended for sickle cell anemia (SCA) patients. The majority of drugs employed in SCA treatment are safely used during breastfeeding, and advantages should supersede any risk when adequately supervised.

Can Women with Sickle Cell Anemia Breastfeed?

Yes. SCD in itself is not a contraindication for breastfeeding. Breastfeeding provides:

  • Immune and nutritional advantages for the infant
  • Emotional attachment
  • Natural contraception assistance in early postpartum (lactational amenorrhea)

Sickle cell anemia genetic counselling during pregnancy

Genetic counselling is an essential aspect of prenatal management in couples in which one or both the partners are HbAS bearers or HbSS anemic patients. It is useful in informing parents about the risk of inheritance, availability of tests, and reproductive decisions.

Objectives of Genetic Counselling during Pregnancy

  • Evaluate fetal risk of inheriting SCD
  • Educate the couple regarding patterns of inheritance and prognosis
  • Explain testing possibilities: prenatal and preimplantation genetic diagnosis (PGD)
  • Support informed decision-making (emotional, ethical, and medical considerations).

Success rates of management of sickle cell anemia during pregnancy in Indian hospitals for African Patients

Overall success rate of patients from different countries of Africa such as Nigeria, Kenya, Ghana, Uganda in Indian hospitals: With advanced multidisciplinary management most pregnancies ended in live births and this is more true in tertiary hospitals.

  • Live birth success rate: ~70-90% at well-managed tertiary care centers
  • Maternal survival: excellent in good hospitals 

Why African Patients Choose GetWellGo for Sickle Cell Anemia and Pregnancy?

GetWellGo is regarded as a leading supplier of healthcare services. We help our patients from Nigeria, Kenya, Uganda to choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for management of sickle cell anemia during pregnancy.
  • Expert doctor with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food

FAQs

How is the flight from Nigeria?

The duration of the flight from Nigeria to India varies with the city of departure, the destination, and whether there are stops on the route or not. 

  • Average Flight Duration
  • From Lagos to New Delhi 
  • Direct (rare): ~10–11 hours 
  • Connecting flights: ~12–16 hours 

How is the flight from Kenya?

Kenya to India flight time varies based on the city of departure, destination and whether you are flying directly or via a stopover.

  • Aggregate Flight Duration
  • Nairobi to New Delhi:
  • Direct flights: ~6–7 hours
  • Connecting flights: ~8–12 hours

Can I pay via wire transfer?

  • Yes, you can make payment by wire transfer for the management of sickle cell anemia during pregnancy in India. Most top-class Indian hospitals cater to African patients and accept African bank (wire) transfer as mode of payment. 

Are there other Nigerians/Kenyans at Fortis?

  • Yes there are definitely Nigerian/Kenyan patients at Fortis hospitals in India, including at Fortis Memorial Research Institute, Gurugram and many other Fortis centers. 

How can I apply for, obtain, or schedule in India?

  • We can assist you in finding the top hospitals in India. 
  • To schedule an appointment for the management of sickle cell anemia during pregnancy in India, contact us via phone at +91-9289678787 or email us at care@getwellgo.com

Recent Blogs